A review study of the use of modified chitosan as a new approach to increase the preservation of blood products (erythrocytes, platelets, and plasma products): ۲۰۱۰-۲۰۲۲
Publish place: Nanomedicine Journal، Vol: 10، Issue: 1
Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 130
This Paper With 17 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_NAMJ-10-1_002
تاریخ نمایه سازی: 18 دی 1401
Abstract:
Due to the unique properties of chitosan (antibacterial and stimulating tissue repair factors) in improving cell function, modified chitosan derivatives are widely used to improve the function of blood products. However, interaction of chitosan positive surface charge with negatively charged blood cells and anionic proteins, increases hemolysis, platelet activation, and dysfunction of plasma proteins, so the use of chitosan in blood applications requires surface modifications. Therefore, in this review study, we review the literature (۲۰۱۰–۲۰۲۲) to determine whether the charged-modified chitosan could eliminate the effects of chitosan on blood products and prepare a platform for more research to improve the preservation of the blood products such as erythrocytes, platelets and plasma proteins (albumin, immunoglobulin (Ig) and factor (FVIII)). Overall, the results of this review study show that negative surface-charged chitosan can increase hematopoiesis and increase the preservation of erythrocytes, platelet, and plasma products. Modified chitosan can be used as an anticoagulant compound for purification and filtration of plasma proteins, gene transfer of FVIII, and to increase the stability of plasma proteins. In addition, due to its antibacterial and hemostatic properties, negatively charged chitosan can stimulate coagulation factors and rapid wound healing and can be used in the production of wound dressings. This review study provides researchers with a new insight into the effectiveness of negative-charged chitosan in improving the preservation of blood products including erythrocytes, platelets, and plasma products (albumin, immunoglobulin, and FVIII) and promises to increase the efficacy of negative-charged chitosan in the future research.
Keywords:
Authors
Tahereh Zadeh Mehrizi
Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
Mehdi Shafiee Ardestani
Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
Seyed Mahdi Rezayat
Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Ahmad Javanmard
Cancer & Nutrition Researcher, Department of Nutrition, Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :